c‐Myc being a downstream target of the NOTCH pathway, it may be possible to overcome GSI resistance in T‐ALL tumors by combining GSIs with compounds that block c‐Myc activity. The gene discussed is MYC; the disease is acute lymphoblastic leukemia.